Restricted stock grant boosts PAVmed (PAVM) director’s holdings
Rhea-AI Filing Summary
White Debra reported acquisition or exercise transactions in this Form 4 filing.
PAVmed Inc. director Debra White received a grant of 13,930 shares of restricted common stock as compensation. The award was granted at $0.00 per share under the company’s Seventh Amended and Restated 2014 Long-Term Incentive Equity Plan and has a single vesting date of May 20, 2029. The shares are subject to forfeiture if the required service period is not completed. Following this grant, White directly holds 21,097 shares of PAVmed common stock.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 13,930 | $0.00 | -- |
Footnotes (1)
- [object Object]
Key Figures
Key Terms
restricted stock financial
vesting financial
forfeiture financial
Long-Term Incentive Equity Plan financial
FAQ
What insider transaction did PAVmed (PAVM) director Debra White report?
Debra White reported receiving 13,930 shares of restricted PAVmed common stock as a grant. The award was made at $0.00 per share under the company’s long-term incentive equity plan and represents compensation rather than an open-market purchase or sale.
Was Debra White’s PAVmed stock transaction a market purchase or sale?
The reported transaction was not a market purchase or sale. It was a grant or award acquisition of 13,930 restricted shares at $0.00 per share, provided as equity compensation under PAVmed’s long-term incentive equity plan rather than through open-market trading.
What plan governs Debra White’s restricted stock grant at PAVmed (PAVM)?
The restricted stock grant was made under PAVmed’s Seventh Amended and Restated 2014 Long-Term Incentive Equity Plan. This plan provides equity-based compensation, including restricted stock awards, with vesting and forfeiture conditions tied to continued service.